Literature DB >> 25046988

Prostate PDT dosimetry.

Timothy C Zhu1, Jarod C Finlay.   

Abstract

We provide a review of the current state of dosimetry in prostate photodynamic therapy (PDT). PDT of the human prostate has been performed with a number of different photosensitizers and with a variety of dosimetry schemes. The simplest clinical light dose prescription is to quantify the total light energy emitted per length (J/cm) of cylindrical diffusing fibers (CDF) for patients treated with a defined photosensitizer injection per body weight. However, this approach does not take into account the light scattering by tissue and usually underestimates the local light fluence rate, and consequently the fluence. Techniques have been developed to characterize tissue optical properties and light fluence rates in vivo using interstitial measurements during prostate PDT. Optical methods have been developed to characterize tissue absorption and scattering spectra, which in turn provide information about tissue oxygenation and drug concentration. Fluorescence techniques can be used to quantify drug concentrations and photobleaching rates of photosensitizers.

Entities:  

Year:  2006        PMID: 25046988      PMCID: PMC4469490          DOI: 10.1016/j.pdpdt.2006.08.002

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  93 in total

1.  Comparison between isotropic and nonisotropic dosimetry systems during intraperitoneal photodynamic therapy.

Authors:  T G Vulcan; T C Zhu; C E Rodriguez; A Hsi; D L Fraker; P Baas; L H Murrer; W M Star; E Glatstein; A G Yodh; S M Hahn
Journal:  Lasers Surg Med       Date:  2000       Impact factor: 4.025

2.  Modeling the output ratio in air for megavoltage photon beams.

Authors:  T C Zhu; B E Bjärngard; Y Xiao; C J Yang
Journal:  Med Phys       Date:  2001-06       Impact factor: 4.071

3.  Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin.

Authors:  S C Chang; G Buonaccorsi; A MacRobert; S G Bown
Journal:  Int J Cancer       Date:  1996-08-07       Impact factor: 7.396

4.  Expression of optical diffusion coefficient in high-absorption turbid media.

Authors:  T Nakai; G Nishimura; K Yamamoto; M Tamura
Journal:  Phys Med Biol       Date:  1997-12       Impact factor: 3.609

5.  Determination of optical properties and blood oxygenation in tissue using continuous NIR light.

Authors:  H Liu; D A Boas; Y Zhang; A G Yodh; B Chance
Journal:  Phys Med Biol       Date:  1995-11       Impact factor: 3.609

6.  Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate.

Authors:  B W Henderson; T M Busch; L A Vaughan; N P Frawley; D Babich; T A Sosa; J D Zollo; A S Dee; M T Cooper; D A Bellnier; W R Greco; A R Oseroff
Journal:  Cancer Res       Date:  2000-02-01       Impact factor: 12.701

7.  Effect of photodynamic therapy on recurrent pituitary adenomas: clinical phase I/II trial--an early report.

Authors:  P V Marks; P E Belchetz; A Saxena; U Igbaseimokumo; S Thomson; M Nelson; M R Stringer; J A Holroyd; S B Brown
Journal:  Br J Neurosurg       Date:  2000-08       Impact factor: 1.596

8.  In vivo reflectance measurement of optical properties, blood oxygenation and motexafin lutetium uptake in canine large bowels, kidneys and prostates.

Authors:  Michael Solonenko; Rex Cheung; Theresa M Busch; Alex Kachur; Gregory M Griffin; Theodore Vulcan; Timothy C Zhu; Hsing-Wen Wang; Stephen M Hahn; A G Yodh
Journal:  Phys Med Biol       Date:  2002-03-21       Impact factor: 3.609

9.  Assessment of cutaneous photosensitivity of TOOKAD (WST09) in preclinical animal models and in patients.

Authors:  Robert A Weersink; Jason Forbes; Stuart Bisland; John Trachtenberg; Mostafa Elhilali; Pierre H Brún; Brian C Wilson
Journal:  Photochem Photobiol       Date:  2005 Jan-Feb       Impact factor: 3.421

10.  Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer.

Authors:  P-J Lou; H R Jäger; L Jones; T Theodossy; S G Bown; C Hopper
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640

View more
  18 in total

Review 1.  The role of photodynamic therapy (PDT) physics.

Authors:  Timothy C Zhu; Jarod C Finlay
Journal:  Med Phys       Date:  2008-07       Impact factor: 4.071

2.  Macroscopic Modeling of the singlet oxygen production during PDT.

Authors:  Timothy C Zhu; Jarod C Finlay; Xiaodong Zhou; Jun Li
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2007-03-06

3.  Modeling light fluence rate distribution in optically heterogeneous prostate photodynamic therapy using a kernel method.

Authors:  Jun Li; Timothy C Zhu
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2007-01-20

4.  Integrated light dosimetry system for prostate photodynamic therapy.

Authors:  Jun Li; Timothy C Zhu; Xiaodong Zhou; Dimofte Andreea; Jarod C Finlay
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2008-01-19

5.  A heterogeneous optimization algorithm for reacted singlet oxygen for interstitial PDT.

Authors:  Timothy C Zhu; Martin D Altschuler; Yida Hu; Ken Wang; Jarod C Finlay; Andreea Dimofte; Keith Cengel; Stephen M Hahn
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2010-01

6.  Comparison of singlet oxygen threshold dose for PDT.

Authors:  Timothy C Zhu; Baochang Liu; Michele M Kim; Dayton McMillan; Xing Liang; Jarod C Finlay; Theresa M Busch
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2014-02-01

7.  Photosensitizer fluorescence and singlet oxygen luminescence as dosimetric predictors of topical 5-aminolevulinic acid photodynamic therapy induced clinical erythema.

Authors:  Srivalleesha Mallidi; Sriram Anbil; Seonkyung Lee; Dieter Manstein; Stefan Elrington; Garuna Kositratna; David Schoenfeld; Brian Pogue; Steven J Davis; Tayyaba Hasan
Journal:  J Biomed Opt       Date:  2014-02       Impact factor: 3.170

8.  A heterogeneous algorithm for PDT dose optimization for prostate.

Authors:  Martin D Altschuler; Timothy C Zhu; Yida Hu; Jarod C Finlay; Andreea Dimofte; Ken Wang; Jun Li; Keith Cengel; S B Malkowicz; Stephen M Hahn
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2009-02-18

9.  Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen.

Authors:  Hiral Patel; Rosemarie Mick; Jarod Finlay; Timothy C Zhu; Elizabeth Rickter; Keith A Cengel; S Bruce Malkowicz; Stephen M Hahn; Theresa M Busch
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

10.  Determination of optical properties in heterogeneous turbid media using a cylindrical diffusing fiber.

Authors:  Andreea Dimofte; Jarod C Finlay; Xing Liang; Timothy C Zhu
Journal:  Phys Med Biol       Date:  2012-09-12       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.